Medscape October 30, 2024
Megan Brooks

PHILADELPHIA — Researchers have developed an artificial intelligence (AI) tool capable of detecting and differentiating cystic and solid pancreatic lesions during endoscopic ultrasound (EUS) with high accuracy.

This was a transatlantic collaborative effort involving researchers in Portugal, Spain, the United States, and Brazil, and the AI tool “works on different platforms and different devices,” Miguel Mascarenhas, MD, PhD, with Centro Hospitalar Universitário de São João, Porto, Portugal, said in a presentation on October 28 at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting.

Mascarenhas noted that pancreatic cystic lesions (PCLs) are a common incidental finding during imaging and are differentiated by whether they’re mucinous PCLs (M-PCLs) or non-mucinous PCLs (NM-PCLs). The malignancy risk is almost exclusive of PCL...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Conferences / Podcast, Provider, Technology, Trends
Cutting through the AI hype to ensure investments have impacts
3 Key Metrics Businesses Must Use To Measure AI And Data Monetization ROI
Privacy And Trust In The AI Age
Oracle to launch new AI-backed EHR in 2025
HLTH 2024: Why nurses are demanding a voice in AI in healthcare

Share This Article